Evidence map›Paper›PMID 32839016›Full record

ReviewTrends in genetics : TIG2020

Emerging Insights into the Distinctive Neuronal Methylome.

Adam W Clemens, Harrison W Gabel

Open access · greenAbstract readReview
In one paragraph

Review in Trends in genetics : TIG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. State-of-the-art therapies for Rett syndrome.Developmental medicine and child neurology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adam W ClemensDepartment of Neuroscience, Washington University School of Medicine, St Louis, MO 63110-1093, USA.
Harrison W GabelDepartment of Neuroscience, Washington University School of Medicine, St Louis, MO 63110-1093, USA. Electronic address: gabelh@wustl.edu.
Washington University in St. Louis · US

Funding

MECHANISMS OF EPIGENETIC REGULATION IN NERVOUS SYSTEM DEVELOPMENTR01MH117405 · NIMH · WASHINGTON UNIVERSITY · PI Harrison W Gabel · 2019 to 2026
$3.9M
Understanding transcriptional mechanisms critical for neural developmentF31NS108574 · NINDS · WASHINGTON UNIVERSITY · PI CLEMENS, ADAM WINFIELD · 2018 to 2019
$61k
NIMH NIH HHS R01 MH117405NINDS NIH HHS F31 NS108574
6 · The paper itself

Abstract

The genomes of mammalian neurons are enriched for unique forms of DNA methylation, including exceptionally high levels of non-CG methylation. Here, we review recent studies defining how non-CG methylation accumulates in neurons and is read out by the critical regulator of neuronal transcription, MeCP2. We discuss the role of gene expression and genome architecture in establishing non-CG methylation and highlight emerging mechanistic insights into how non-CG methylation and MeCP2 control transcription. Further, we describe the cell type-specific functions of this methylation and explore growing evidence that disruption of this regulatory pathway contributes to neurodevelopmental disorders. These findings uncover how the distinctive epigenome in neurons facilitates the development and function of the complex mammalian brain.

Indexed as

DNA MethylationEpigenomeGene Expression RegulationGenomeAnimalsBrainHumansNeurodevelopmental DisordersNeuronsDNMT3Agene regulationmCHMeCP2neurodevelopmental disordersnon-CG DNA methylation

Identifiers

PMID32839016
PMCPMC7572801
OpenAlexW3080779166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.